Comparison of characteristics between nonobese and overweight/obese subjects with nonalcoholic fatty liver disease in a south indian population

Diabetes Technology and Therapeutics

Volumn 16, Issue 1, 2014, Pages 48-55

  Vendhan, Ramanujam ^a   Amutha, Anandakumar ^a   Anjana, Ranjit Mohan ^a   Unnikrishnan, Ranjit ^a   Deepa, Mohan ^a   Mohan, Viswanathan ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; ARTICLE; BODY MASS; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INDIAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; OBESITY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; URBAN AREA; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; ELECTROCARDIOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASTING; FATTY LIVER; FEMALE; HUMANS; HYPERTENSION; INDIA; INFLAMMATION; INSULIN RESISTANCE; MALE; MASS SCREENING; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; RISK FACTORS; THINNESS;

EID: 84891872376     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0165     Document Type: Article

References (57)

1. Bellentani S, Scaglioni F, Marino M, Bedogni G: Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010;28: 155-161.
2. Neuschwander-Tetri BA, Caldwell SH: Nonalcoholic steatohepatitis: Summary of an AASLD single topic conference. Hepatology 2003;37:1202-1219. (Pubitemid 36538699)
3. Tolman KG, Fonseca V, Dalpiaz A, TanMH: Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care 2007;30:734-743. (Pubitemid 46354365)
4. Targher G: Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: The plot thickens. Diabet Med 2007;24:1-6. (Pubitemid 46103064)
5. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
6. Mulhall BP, Ong JP, Younossi ZM: Non-alcoholic fatty liver disease: An overview. J Gastroenterol Hepatol 2002;17: 1136-1143. (Pubitemid 36015607)
7. Socha P, Wierzbicka A, Neuhoff-Murawska J, W1odarek D, Podleśny J, Socha J: Nonalcoholic fatty liver disease as a feature of the metabolic syndrome. Rocz Panstw Zakl Hig 2007;58:129-137.
8. Koh JH, Shin YG, Nam SM, Lee MY, Chung CH, Shin JY: Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Diabetes Care 2009;32:147-152.
9. Kotronen A, Yki-Jarvinen H: Fatty liver: A novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28:27-38.
10. Argo CK, Caldwell SH: Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis 2009;13:511-531.
11. Angulo P: GI epidemiology: Nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007;25:883-889.
12. Chitturi S, Wong VW, Farrell G: Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground. J Gastroenterol Hepatol 2011;26(Suppl 1):163-172.
13. Hamaguchi M, Takeda N, Kojima T, Ohbora A, Kato T, Sarui H, Fukui M, Nagata C, Takeda J: Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J Gastroenterol 2012;18:1508-1516.
14. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-923. (Pubitemid 36397405)
15. Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, Srishord M: Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore) 2012;91:319-327.
16. Margariti A, Deutsch M, Manolakopoulos S, Tiniakos D, Papatheodoridis GV: The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease. J Clin Gastroenterol 2013;47: 280-286.
17. Kim SH, Lee JW, Hwang HJ: Associations between combinations of body mass index plus non-alcoholic fatty liver disease and diabetes mellitus among Korean adults. Asia Pac J Clin Nutr 2011;20:14-20.
18. Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, Dhibar T, Bhattacharya B, Bhattacharya D, Manna B, Dhali GK, Santra A, Chowdhury A: Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 2010;51: 1593-1602.
19. Kwon YM, Oh SW, Hwang SS, Lee C, Kwon H, Chung GE: Association of non alcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am J Gastroenterol 2012;107:1852-1858.
20. Choudhary NS, Duseja A, Kalra N, Das A, Dhiman RK, Chawla YK: Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease. Ann Hepatol 2012;11:478-486.
21. Deepa M, Pradeepa R, Rema M, Mohan A, Deepa R, Shanthirani S, Mohan V: The Chennai Urban Rural Epidemiology Study (CURES) - study design and methodology (urban component) (CURES-I). J Assoc Physicians India 2003;51: 863-870. (Pubitemid 41279865)
22. Deepa M, Farooq S, Datta M, Deepa R, Mohan V: Prevalence of metabolic syndrome using WHO, ATP III and IDF definitions in Asia Indians; the Chennai Urban Rural Epidemiology Study. Diabetes Metab Res Rev 2007;23:127-134.
23. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998;15:539-553. (Pubitemid 28319935)
24. National High Blood Pressure Education Program: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JNC 7 Express. Bethesda, MD: National Heart Lung and Blood Institute Health Information Center, 2003:1-52.
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
26. World Health Organization, Western Pacific Region: The Asia Pacific Perspective. Redefining Obesity and Its Treatment. Melbourne: World Health Organization, International Association for the Study of Obesity and International Obesity Task Force, International Diabetes Institute, 2000.
27. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD: Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991;43:26-31.
28. Lonardo A, Bellini M, Tartoni P, Tondelli E: The bright liver syndrome. Prevalence and determinants of a ''bright'' liver echopattern. Ital J Gastroenterol Hepatol 1997;29:351-356. (Pubitemid 28059513)
29. Misra A, Khurana L: Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008;71(11 Suppl 1):S9-S30.
30. Misra A, Khurana L: The metabolic syndrome in South Asians: Epidemiology, determinants, and prevention. Metab Syndr Relat Disord 2009;6:497-514.
31. WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
32. Moreno Sanchez D: Patogenia de la hepatopat́agrasa no alcoholic primaria. Med Clin (Barc) 2005;124:668-677.
33. Diehl AM: Nonalcoholic steatohepatitis pathogenesis. In: Arroyo V, Forns X, Garcia-Pagan JC, eds. Progress in the Treatment of Liver Diseases. Barcelona: Ars Medica, 2003: 227-232.
34. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, Rizzetto M: Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association. Hepatology 2002;35:367-372. (Pubitemid 34106376)
35. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN: Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-1192. (Pubitemid 32246672)
36. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607. (Pubitemid 19004941)
37. Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Lim SK, Kim KR, Lee HC, Huh KB, Cha BS: Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004;164:2169-2175.
38. Tsochatzis EA, Manolakopoulos S, Papatheodoridis GV, Archimandritis AJ: Insulin resistance and metabolic syndrome in chronic liver diseases: Old entities with new implications. Scand J Gastroenterol 2009;44:6-14.
39. Cohen JC, Horton JD, Hobbs HH: Human fatty liver disease: Old questions and new insights. Science 2011;332:1519-1523.
40. Puppala J, Siddapuram SP, Akka J, Munshi A: Genetics of nonalcoholic fatty liver disease: An overview. J Genet Genom 2013;40:15-22.
41. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S: Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes. Hepatology 2008;48:792-798.
42. Wong VW, Wong GL, Tsang SW, Hui AY, Chan AW, Choi PC, Chim AM, Chu S, Chan FK, Sung JJ, Chan HL: Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Aliment Pharmacol Ther 2009;29:387-396.
43. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P: The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005;129:113-121. (Pubitemid 41002048)
44. Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ: Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005;112:666-673. (Pubitemid 41099045)
45. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Okuda J, Ida K, Yoshikawa T: Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007;13:1579-1584. (Pubitemid 46672668)
46. Arslan U, Turkoglu S, Balcioglu S, Tavil Y, Karakan T, Cengel A: Association between nonalcoholic fatty liver disease and coronary artery disease. Coronary Artery Dis 2007;18:433-436. (Pubitemid 47262963)
47. Nakao H, Yoneda M: The intertwisted correlations among non-alcoholic fatty liver disease, atherosclerosis, and metabolic syndrome. J Gastroenterol 2009;44:1162-1164.
48. Targher G, Arcaro G: Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007;191:235-240. (Pubitemid 46400718)
49. McKimmie RL, Daniel KR, Carr JJ, Bowden DW, Freedman BI, Register TC, Hsu FC, Lohman KK, Weinberg RB, Wagenknecht LE: Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: The Diabetes Heart Study. Am J Gastroenterol 2008;103:3029-3035.
50. Lorbek G., Rozman D: Cholesterol and inflammation at the crossroads of non-alcoholic fatty liver disease (NAFLD) and atherogenesis. In: Parthasarathy S, ed. Atherogenesis. Rijeka, Croatia: InTech, 2012:281-304.
51. Akabame S, Hamaguchi M, Tomiyasu K, Tanaka M, Kobayashi-Takenaka Y, Nakano K, Oda Y, Yoshikawa T: Evaluation of vulnerable coronary plaques and nonalcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). Circ J 2008;72:618-625. (Pubitemid 351679416)
52. Sun L, Lu SZ: Association between non-alcoholic fatty liver disease and coronary artery disease severity. Chin Med J 2011;124:867-872.
53. Thiruvagounder M, Khan S, Sheriff DS: Non-alcoholic fatty liver disease (NAFLD) - is it an emerging risk factor for coronary artery disease Preliminary study in a local Indian population. Sultan Qaboos Univ Med J 2010;10: 221-226.
54. Chen CH, Nien CK, Yang CC, Yeh YH: Association between nonalcoholic fatty liver disease and coronary artery calcification. Dig Dis Sci 2010;55:1752-1760.
55. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM: Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A metaanalysis. Hepatology 2011;13:1082-1090.
56. Palmentieri B, Sio I, La Mura V, Masarone M, Vecchione R, Bruno S, Torella R, Persico M: The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006;38:485-489. (Pubitemid 44356237)
57. Valls C, Iannacconne R, Alba E, Murakami T, Hori M, Passariello R, Vilgrain V: Fat in the liver: Diagnosis and characterization. Eur Radiol 2006;6:2292-2308. (Pubitemid 44349878)